Page last updated: 2024-10-29
iodixanol and Aneurysm, Iliac
iodixanol has been researched along with Aneurysm, Iliac in 1 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "Aortoiliac aneurysm imaging can be performed with substantially reduced amounts of contrast medium using 64-detector computed tomography angiography technology." | 1.35 | Adequacy of an early arterial phase low-volume contrast protocol in 64-detector computed tomography angiography for aortoiliac aneurysms. ( Benenati, JF; Diehm, N; Katzen, BT; Pena, C; Tsoukas, AI, 2008) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Diehm, N | 1 |
| Pena, C | 1 |
| Benenati, JF | 1 |
| Tsoukas, AI | 1 |
| Katzen, BT | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Does Reduction in Contrast Administration Dose in Computed Tomography Arteriograms Degrade Image Quality? A Single Institutional Review of an Ultra-low Contrast Dose Protocol[NCT02669784] | | 34 participants (Actual) | Interventional | 2016-02-29 | Completed |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trial Outcomes
Ascending Sinotubular Junction Measurement
Following image acquisition, quantitative analysis was performed by measurement of the attenuation of the contrast bolus by use of Hounsfield Units. Measurement was taken at the ascending aorta near the sinotubular junction. (NCT02669784)
Timeframe: At 30 days
| Intervention | Hounsfield units (Mean) |
|---|
| Contrast (Omnipaque) Low Dose (40mL) | 246.4 |
| Contrast (Omnipaque) Low Dose (50mL) | 287.5 |
Burfication Measurement
Following image acquisition, quantitative analysis was performed by measurement of the attenuation of the contrast bolus by use of Hounsfield Units. A measurement was taken from the distal abdominal aorta prior to the bifurcation. (NCT02669784)
Timeframe: 30 days
| Intervention | Hounsfield units (Mean) |
|---|
| Contrast (Omnipaque) Low Dose (40mL) | 336.2 |
| Contrast (Omnipaque) Low Dose (50mL) | 321.2 |
Celiac Measurement
Following image acquisition, quantitative analysis was performed by measurement of the attenuation of the contrast bolus by use of Hounsfield Units. A measurement was taken from the proximal abdominal aorta at the level of the celiac axis. (NCT02669784)
Timeframe: 30 days
| Intervention | Hounsfield units (Mean) |
|---|
| Contrast (Omnipaque) Low Dose (40mL) | 243.8 |
| Contrast (Omnipaque) Low Dose (50mL) | 329.5 |
CTA Vessel Opacification Grading 1
"5 Point Grading Scale was used to determine CTA Vessel Opacification by a Board Certified Radiologist.~Poor opacification with no difference in attenuation of the lumen compared to the wall of the vessel. Non diagnostic.~Decreased opacification. Little to no difference in attenuation between the lumen and the wall. Non diagnostic.~Moderate opacification of the lumen of the vessel. Diagnostic study.~Good opacification of the lumen of the vessel.~Excellent opacification of the lumen of the vessel with distinct difference in attenuation of the wall and lumen of the vessel." (NCT02669784)
Timeframe: 30 days
| Intervention | score on a scale (Mean) |
|---|
| Contrast (Omnipaque) Low Dose (40mL) | 4 |
| Contrast (Omnipaque) Low Dose (50mL) | 4.3 |
CTA Vessel Opacification Grading 2
"5 Point Grading Scale was used to determine CTA Vessel Opacification by a second Board Certified Radiologist.~Poor opacification with no difference in attenuation of the lumen compared to the wall of the vessel. Non diagnostic.~Decreased opacification. Little to no difference in attenuation between the lumen and the wall. Non diagnostic.~Moderate opacification of the lumen of the vessel. Diagnostic~Good opacification of the lumen of the vessel.~Excellent opacification of the lumen of the vessel with distinct difference in attenuation of the wall and lumen of the vessel." (NCT02669784)
Timeframe: 30 days
| Intervention | score on a scale (Mean) |
|---|
| Contrast (Omnipaque) Low Dose (40mL) | 4.2 |
| Contrast (Omnipaque) Low Dose (50mL) | 4.4 |
Descending Thoracic Aorta Measurement
Following image acquisition, quantitative analysis was performed by measurement of the attenuation of the contrast bolus by use of Hounsfield Units. A measurement was taken from the distal abdominal aorta prior to the bifurcation. (NCT02669784)
Timeframe: 30 days
| Intervention | Hounsfield units (Mean) |
|---|
| Contrast (Omnipaque) Low Dose (40mL) | 261.9 |
| Contrast (Omnipaque) Low Dose (50mL) | 312.8 |
Left Common Femoral Artery Measurement
Following image acquisition, quantitative analysis was performed by measurement of the attenuation of the contrast bolus by use of Hounsfield Units. A measurement was taken from the right common femoral artery. (NCT02669784)
Timeframe: 30 days
| Intervention | Hounsfield units (Mean) |
|---|
| Contrast (Omnipaque) Low Dose (50mL) | 309.5 |
Right Common Femoral Artery Measurement
Following image acquisition, quantitative analysis was performed by measurement of the attenuation of the contrast bolus by use of Hounsfield Units. A measurement was taken from the right common femoral artery. (NCT02669784)
Timeframe: 30 days
| Intervention | Hounsfield units (Mean) |
|---|
| Contrast (Omnipaque) Low Dose (50mL) | 314.5 |
Other Studies
1 other study available for iodixanol and Aneurysm, Iliac